MARC details
000 -LEADER |
fixed length control field |
02308cam a2200325 a 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
EG-GiCUC |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
160929s2016 ua f m 000 0 eng d |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
EG-GiCUC |
Language of cataloging |
eng |
Transcribing agency |
EG-GiCUC |
041 0# - LANGUAGE CODE |
Language code of text/sound track or separate title |
eng |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
Deposite |
097 ## - Thesis Degree |
Thesis Level |
M.Sc |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
Classification number |
Cai01.19.05.M.Sc.2016.Af.M |
100 0# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Afaf Mohammad Mahmoud |
245 10 - TITLE STATEMENT |
Title |
Micafungin as a prophylactic antifungal during induction phase of chemotherapy for pediatric acute lymphoblastic leukemia / |
Statement of responsibility, etc. |
Afaf Mohammad Mahmoud ; Supervised Lobna Mohamed Shalaby , Hadir Ahmad Elmahallawy , Sahar Ahmad Khalil |
246 15 - VARYING FORM OF TITLE |
Title proper/short title |
للوقاية من الاصابة بالفطريات خلال الفترة التحفيزية من علاج سرطان الدم الليمفاوى الحاد فى الاطفال Micafungin استخدام عقار المايكافنجين |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Cairo : |
Name of publisher, distributor, etc. |
Afaf Mohammad Mahmoud , |
Date of publication, distribution, etc. |
2016 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
89 P. ; |
Dimensions |
25cm |
502 ## - DISSERTATION NOTE |
Dissertation note |
Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Pediatric Oncology |
520 ## - SUMMARY, ETC. |
Summary, etc. |
Background: Invasive fungal infection (IFI) remains a major cause of infectious morbidity and mortality in neutropenic patients receiving chemotherapy or hematopoietic stem cell transplantation (HSCT). Micafungin exhibits broad antifungal activity against both Aspergillus and Candida species. Objective: We performed a prospective study to determine the efficacy, safety, and tolerability of prophylactic micafungin against IFI in pediatric neutropenic patients during induction chemotherapy for acute lymphoblastic leukemia (ALL). Results: Treatment success rate, defined as absence of proven, probable, or possible IFIs, was 75%. No adverse events were observed that could be related to micafungin prophylaxis. Conclusions: These results suggest that prophylactic micafungin is well tolerated and may prevent IFIs in pediatric patients with neutropenia receiving chemotherapy |
530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE |
Additional physical form available note |
Issued also as CD |
653 #4 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
ALL |
653 #4 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Induction chemotherapy |
653 #4 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Pediatric |
700 0# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Hadir Ahmad Elmahallawy , |
Relator term |
|
700 0# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Lobna Mohamed Shalaby , |
Relator term |
|
700 0# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Sahar Ahmad Khalil , |
Relator term |
|
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN) |
Cataloger |
Nazla |
Reviser |
Revisor |
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN) |
Cataloger |
Soheir |
Reviser |
Cataloger |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Dewey Decimal Classification |
Koha item type |
Thesis |